Clinical Development of AAV Based Gene Therapies for Glomerular Diseases

11:30 am - Thursday 18th March 2027

  • Expected side effects of AAV-based gene therapies, and mitigation strategies
  • Operationalizing gene therapies in nephrology
  • Current and coming clinical gene therapies targeting glomerular diseases

Speakers:

Chief Medical Officer
Purespring Therapeutics